This webinar was supported by Medtronic

Learning Objectives

• New evidence and increasing the awareness of atrial fibrillation (AF) in cryptogenic stroke patients.
• Treatment approaches from the guidelines and the latest study evidence.
• AF, stroke, and related symptoms, and why the evidence from the past is important.

Why ESUS needs prolonged monitoring and how new data may benefit patients.

REFERENCES 

1. Adams HJ, Bendixen B, Kappelle L, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.
2. Hart R, Diener H, Coutts S, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet. 2014;13(4):429-438.
3. Grond M, Jauss M, Hamann G, et al. Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study. Stroke. 2013;44(12):3357-3364.
4. Rizos T, Günter J, Jenetzky E, et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012;43(10):2689-2694.
5. Sposato L, Cipriano L, Saposnik G, Ruiz Vargas E, Riccio P, Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2015;14(4):377-387.
6. Reiffel J, Verma A, Kowey P, et al. Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study. JAMA Cardiol. 2017;2(10):1120-1127.
7. Wein T, Lindsay M, Côté R, et al. Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017. Int J Stroke. 2018;13(4):420-443.
8. Macle L, Cairns J, Leblanc K, et al. 2016 Focused Update of the Canadian Cardiovascular Guidelines for the Management of Atrial Fibrillation. Can J Cardiol. 2016;32(10):1170-1185.
9. Freedman B, Camm J, Calkins H, et al. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Circulation. 2017;135(19):1851-1867.
10. Rogers J. Detecting Atrial Fibrillation: How Long Should Patients Be Monitored? Pract Neurol. 2016;June:23-24.
11. Wolf P, Abbott R, Kannel W. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987;147(9):1561-1564.
12. Lin H, Wolf P, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke. 1996;27(10):1760-1764.
13. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: Final Results. Circulation. 1991;84(2):527-539.
14. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609-1678.
15. Kotecha D, Piccini J. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36:3250-3257.
16. Sanna T, Diener H-C, Passman R, et al. Cryptogenic stroke and underlying atrial fibrillation. NEJM. 2014;370(26):2478-2486.
17. Rogers J et al. Cryptogenic Stroke Therapy Awareness Presentation. http://www.abstractsonline.com/pp8/#!/4046/presentation/8072 2016. Published 2016. Accessed 7 January, 2020.
18. Ziegler P, Rogers J, Ferreira S, et al. Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population. Int J Cardiol. 2017;244:175-179.
19. Ricci B, Chang A, Hemendinger M, et al. A Simple Score That Predicts Paroxysmal Atrial Fibrillation on Outpatient Cardiac Monitoring after Embolic Stroke of Unknown Source. J Stroke Cerebrovasc Dis. 2018;27(6):1692-1696.
20. Tsivgoulis G, Katsanos A, Grory B, et al. Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia. Stroke. 2019;50(8):2175-2180.
21. Zhang C, Kasner S. Uncertainties About Cardiac Monitoring After Cryptogenic Stroke. Pract Neurol. 2016;July/August:31-33.